- Joined
- Mar 2, 2018
- Messages
- 234
- Reaction score
- 673
I've been following the CRNA related discussions on this forum for a while. Based on these conversations, it would seem as if the degree to which anesthesia is being overrun with CRNAs is a function of a multifactorial calculus: surgeon preference, hospital policies, AMC staffing models, insurance reimbursement policies, etc.
But isn't it really a lot more simple than that? As far as I know, there aren't any unemployed or underemployed CRNAs out there, which means that the demand for CRNAs exceeds their supply. In this light, one could make the argument that the ratio of anesthesiologists to CRNAs is dictated purely by the number of active CRNAs. If you were to increase the supply of CRNAs, then the ratio would shrink, independent of any policy or political changes.
In other words, the extent of the CRNA threat facing anesthesia can be quantified by a simple number rather than a complex interplay of the aforementioned factors: the growth of the CRNA supply. If the number of CRNAs doesn't grow, then even giving them full scope would not damage anesthesiologists too badly, since the CRNAs are already cranking out as much "anesthesia product" as they have the capacity for. Policy changes would not magically give them powers to increase their throughput. Likewise, the market has shown there is currently unmet demand for CRNAs and so growth in their number would lead to a decrease in the doctor:CRNA ratio even absent the removal of restrictions on their scope. So, to see how badly anesthesia is screwed, just look at how quickly they're cranking out CRNAs.
Agree? Disagree?
But isn't it really a lot more simple than that? As far as I know, there aren't any unemployed or underemployed CRNAs out there, which means that the demand for CRNAs exceeds their supply. In this light, one could make the argument that the ratio of anesthesiologists to CRNAs is dictated purely by the number of active CRNAs. If you were to increase the supply of CRNAs, then the ratio would shrink, independent of any policy or political changes.
In other words, the extent of the CRNA threat facing anesthesia can be quantified by a simple number rather than a complex interplay of the aforementioned factors: the growth of the CRNA supply. If the number of CRNAs doesn't grow, then even giving them full scope would not damage anesthesiologists too badly, since the CRNAs are already cranking out as much "anesthesia product" as they have the capacity for. Policy changes would not magically give them powers to increase their throughput. Likewise, the market has shown there is currently unmet demand for CRNAs and so growth in their number would lead to a decrease in the doctor:CRNA ratio even absent the removal of restrictions on their scope. So, to see how badly anesthesia is screwed, just look at how quickly they're cranking out CRNAs.
Agree? Disagree?
Last edited: